Thomas Hofmann

708 total citations
14 papers, 531 citations indexed

About

Thomas Hofmann is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Thomas Hofmann has authored 14 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Thomas Hofmann's work include Cystic Fibrosis Research Advances (7 papers), Tuberculosis Research and Epidemiology (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Thomas Hofmann is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Tuberculosis Research and Epidemiology (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Thomas Hofmann collaborates with scholars based in Germany, United States and Netherlands. Thomas Hofmann's co-authors include Michael R. Knowles, Richard C. Boucher, Tzvy Bistritzer, Bruce S. Keenan, Aaron Hanukoglu, Martin A. Nash, Pierre Barker, Eithne F. MacLaughlin, Eitan Kerem and Zhaoqing Zhou and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Thomas Hofmann

14 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Hofmann Germany 10 317 223 87 77 59 14 531
Samuel Chung United States 10 167 0.5× 323 1.4× 77 0.9× 136 1.8× 56 0.9× 16 646
Lucy A Clunes United States 9 367 1.2× 156 0.7× 54 0.6× 177 2.3× 18 0.3× 22 591
Zuhal Ergönül United States 9 134 0.4× 320 1.4× 15 0.2× 54 0.7× 62 1.1× 11 500
Jaime Chávez Mexico 12 62 0.2× 79 0.4× 46 0.5× 109 1.4× 78 1.3× 27 352
Chong Da Tan United States 10 353 1.1× 165 0.7× 36 0.4× 84 1.1× 7 0.1× 10 511
Catherine A. Doyle United States 9 90 0.3× 129 0.6× 199 2.3× 82 1.1× 91 1.5× 12 455
Bradly Shrum Canada 4 37 0.1× 145 0.7× 115 1.3× 40 0.5× 26 0.4× 5 414
Karin Hammer Germany 15 72 0.2× 344 1.5× 120 1.4× 44 0.6× 88 1.5× 30 860
Shuhua Yuan China 11 92 0.3× 85 0.4× 123 1.4× 54 0.7× 29 0.5× 45 382
Hugo Caire de Castro Faria Neto Brazil 10 32 0.1× 126 0.6× 57 0.7× 33 0.4× 49 0.8× 13 365

Countries citing papers authored by Thomas Hofmann

Since Specialization
Citations

This map shows the geographic impact of Thomas Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hofmann more than expected).

Fields of papers citing papers by Thomas Hofmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hofmann. The network helps show where Thomas Hofmann may publish in the future.

Co-authorship network of co-authors of Thomas Hofmann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Hofmann. A scholar is included among the top collaborators of Thomas Hofmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Hofmann. Thomas Hofmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Doyle‐Eisele, Melanie, et al.. (2023). Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection. Antimicrobial Agents and Chemotherapy. 67(2). e0114422–e0114422. 8 indexed citations
2.
3.
Verma, Deepshikha, Lian J. Pennings, Matthew Zimmerman, et al.. (2019). Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections. Journal of Cystic Fibrosis. 18(5). 714–720. 51 indexed citations
4.
Hofmann, Thomas, et al.. (2019). Inhaled Antibiotics for Mycobacterial Lung Disease. Pharmaceutics. 11(7). 352–352. 26 indexed citations
5.
Scheuch, G., Sebastian Canisius, Thomas Hofmann, et al.. (2018). Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients. Emerging Microbes & Infections. 7(1). 1–8. 19 indexed citations
6.
Vogelmeier, Claus, Péter Kardos, Thomas Hofmann, et al.. (2014). Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. European Respiratory Journal. 45(5). 1273–1282. 16 indexed citations
7.
Siekmeier, R., Thomas Hofmann, & G. Scheuch. (2014). Inhalation of Macrolides: A Novel Approach to Treatment of Pulmonary Infections. Advances in experimental medicine and biology. 839. 13–24. 10 indexed citations
8.
Hofmann, Thomas. (2012). New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa. Current Pharmaceutical Design. 18(5). 683–695. 9 indexed citations
9.
Kerem, Eitan, Tzvy Bistritzer, Aaron Hanukoglu, et al.. (1999). Pulmonary Epithelial Sodium-Channel Dysfunction and Excess Airway Liquid in Pseudohypoaldosteronism. New England Journal of Medicine. 341(3). 156–162. 266 indexed citations
10.
Hofmann, Thomas, et al.. (1998). Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 157(6). 1844–1849. 45 indexed citations
11.
Hofmann, Thomas, et al.. (1997). Conventional and Modified Nasal Potential-Difference Measurement in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 155(6). 1908–1913. 33 indexed citations
12.
Clauss, Wolfgang, et al.. (1997). Cystic fibrosis and non-cystic-fibrosis human nasal epithelium show analogous Na + absorption and reversible block by phenamil. Pflügers Archiv - European Journal of Physiology. 434(1). 19–24. 11 indexed citations
13.
Becker, Tim, et al.. (1990). [Elimination of secretions in CF patients under amiloride inhalation].. PubMed. 44(10). 1148–50. 6 indexed citations
14.
Hofmann, Thomas, et al.. (1981). Comparative evaluation of three methods for measuring gentamicin and tobramycin in serum. Antimicrobial Agents and Chemotherapy. 20(6). 821–825. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Chung Breakdown of academic impact, for papers by Lucy A Clunes Breakdown of academic impact, for papers by Zuhal Ergönül Breakdown of academic impact, for papers by Jaime Chávez Breakdown of academic impact, for papers by Chong Da Tan Breakdown of academic impact, for papers by Catherine A. Doyle Breakdown of academic impact, for papers by Bradly Shrum Breakdown of academic impact, for papers by Karin Hammer Breakdown of academic impact, for papers by Shuhua Yuan Breakdown of academic impact, for papers by Hugo Caire de Castro Faria Neto
Rankless by CCL
2026